Injectable hormone for IVF in women 36-40
Part of Women’s health & pregnancy clinical trials.
This study tests a one-time injection medicine (corifollitropin alfa) to help older women produce eggs for IVF. It aims to see if this medicine is safe and works well for women aged 36 to 40 with normal ovarian function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a married woman between 36 and 40 years old.
- Your ovarian function is considered normal (based on blood tests like AMH and FSH).
- You are planning to use an IVF/ICSI procedure with a specific medication protocol (called 'antagonist protocol').
- You have not had more than 2 previous IVF stimulation cycles.
- You have not had 3 or more pregnancy losses or repeated failed embryo transfers.
- You do not have conditions that increase risk of ovarian hyperstimulation syndrome (OHSS) or poor ovarian response.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding a hormone called r-hLH to standard IVF treatment helps women aged 35 to 40 produce better eggs and improve their chances of pregnancy. It is for women who are on their first or second cycle of assisted reproduction.
This study tests if a combination of two hormone drugs (follitropin alfa/lutropin alfa) works as well as another drug (hMG) for Japanese women with low LH and FSH levels who are doing in vitro fertilization (IVF). The goal is to help them produce eggs for pregnancy.
This trial tests a fertility drug called follitropin delta for women undergoing IVF. It checks if using this drug with a specific hormone-lowering protocol helps produce eggs for fertilisation.
This study looks at how follitropin delta is used in real clinics to help women stimulate eggs for IVF or ICSI. It may help doctors fine-tune dosing by comparing outcomes in everyday practice.
This trial tests whether adding a personalized amount of “LH” during IVF hormone stimulation can help your ovaries respond better. It may be useful if you’ve had a weaker IVF response before and fit specific age and egg-quality markers.
This trial is studying whether a specific fertility medication (hMG) helps improve embryo quality during IVF when you are also doing genetic testing of embryos. It may help you have better embryos for transfer.
Hear when a new Infertility trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.